Ankylosing spondylitis and gestation
DOI:
https://doi.org/10.33448/rsd-v11i15.37129Keywords:
Ankylosing spondylitis; Gestation; Consequences; Immunosuppressive drug.Abstract
Characterized by low back pain, morning stiffness, fatigue and progressive functional limitation, Ankylosing Spondylitis (AS), a chronic inflammatory disease, considered part of the spondyloarthritis group. Often confused with other pathologies due to the complaint of low back pain being common in the general population. This literature review sought to clarify and investigate the development of Ankylosing Spondylitis during the gestational period. Through the selection of articles, using the Scielo platform (Scientific Electronic Library Online) and PubMed, 55 articles were selected, of which 17 supported this review. Through bibliographic research carried out through searches for the descriptors “ankylosing spondylitis and pregnancy” (ankylosing spondylitis and pregnancy), “treatment of ankylosing spondylitis in pregnancy” (treatment of ankylosing spondylitis in pregnancy/ el embarazo), “complications of ankylosing spondylitis in pregnancy” (complications of ankylosing spondylitis in pregnancy/complicaciones de la ankylosing spondylitis in el embarazo), “risk factors of pregnancy with ankylosing spondylitis” (risk factors of pregnancy with ankylosing spondylitis/factors of risk for embarassment with ankylosing spondylitis). Associated with the gestational picture and the limitations of the disease with the interruption of treatment, there is a probability that the gestational period will lead to the progression of the disease for the carrier.
References
Barros, P. D. S., Bértolo, M. B., & Samara, A. M. (2005). Perfil Gestacional na Espondilite Anquilosante. Revista Brasileira de Reumatologia, v. 45(3), p. 103-106. doi.org/10.1590/S0482-50042005000300003.
Barros, S., Degrava, P., Keiserman ,M., Meirelles, E. S., Pinheiro, M. M., Ximenes, A. C., ... & Gonçalves, C. R. (2013). Recomendações sobre diagnóstico e tratamento da espondilite anquilosante. Revista Brasileira de Reumatologia. v. 53(3), p. 242-257.
Bröms, G., Kieler, H.., Ekbom, A., Gissler, M.., Hellgren, K., Leinonen, M. K., Pedersen, L., Schmitt-Egenolf, M., Toft Sørensen, H., & Granath, F. (2020). Paediatric infections in the first 3 years of life after maternal anti-TNF treatment during pregnancy. Aliment Pharmacol Ther. p. 843-854. doi: 10.1111/apt.15971.
Carnovale, C., Parisi, F., Battini, V., Zavatta, A., Cheli, S., Cattaneo, D., Gringeri, M., Mosini, G., Guarnieri, G., Cammarata, G., & Cetin, I. (2021). The use of biological agents in pregnant women affected by autoimmune disorders: Why we need more research of this neglected area. Pharmacological Research. v. 171. 171:105786. doi: 10.1016/j.phrs.2021.105786.
Desai, R. J., Bateman, B. T., Huybrechts, K. F., Patorno, E., Hernandez-Diaz, S., Park, Y., Dejene, S. Z., Cohen, J., Mogun, H., & Kim, S. C. (2017). Risk of serious infections associated with use of immunosuppressive agents in pregnant women with autoimmune inflammatory conditions: cohort study. BMJ. p. 895. doi: 10.1136/bmj.j895.
Desai, R. J., Huybrechts, K. F., Bateman, B. T., Hernandez-Diaz, S., Mogun, H., Gopalakrishnan, C., Patorno, E., & Kim, S. C. (2016). Brief Report: Patterns and Secular Trends in Use of Immunomodulatory Agents During Pregnancy in Women With Rheumatic Conditions. Arthritis Rheumatol. p. 1183-9. doi: 10.1002/art.3952.
Genest, G., Spitzer, K. A., & Laskin, C. A. (2018) Maternal and Fetal Outcomes in a Cohort of Patients Exposed to Tumor Necrosis Factor Inhibitors throughout Pregnancy. J Rheumatol. p. 1109-1115. doi: 10.3899/jrheum.171152.
Hoffman, S.L., Zaphiratos, V., Girard, M.A., Boucher, M., & Crochetière, C. (2012). Failed epidural analgesia in a parturient with advanced ankylosing spondylitis: a novel geexplanation. Can J Anaesth. p. 871- 874. doi: 10.1007/s12630-012-9745-1.
Jethwa, H., & Bowness, P. (2016) The interleukin (IL)-23/IL-17 axis in ankylosing spondylitis: new advances and potentials for treatment. Clinical and experimental immunology. v. 183 (1), p. 30-36. doi: 10.1111/cei.12670.
Lee, J. S., Oh, J. S., Kim, Y. J., Hong, S., Lee, C. K., Yoo, B., & Kim, Y. G. (2019). Effects of Pregnancy and Delivery Methods on Change in Ankylosing Spondylitis Treatment Using the Korean Health Insurance Review and Assessment Service Claims Database. J Korean Med Sci, p. 34-37. doi: 10.3346/jkms.2019.34.e238.
Lee, J. S., Oh, J. S., Kim, Y. J., Hong, S., Lee, C. K., Yoo, B., & Kim, Y. G. (2020). Reasons for the High Cesarean Delivery Rate among Women with Ankylosing Spondylitis: Using the Korean National Health Insurance Database. J Rheumatol. p. 668-673. doi: 10.3899/jrheum.190754.
Machado, A. A. M. (2015) Análise farmacoepidemiológica e farmacoeconômica do tratamento da espondilite anquilosante com os bloqueadores do fator de necrose tumoral (TNF), Tese (Mestrado) - Programa de Pós-Graduação em Saúde Pública da Universidade Federal de Minas Gerais, Minas Gerais. v. 167.
Maguire, S., O'Dwyer, T., Mockler, D., O'Shea, F., & Wilson, F. (2020). Pregnancy in axial spondyloarthropathy: A systematic review & meta-analysis. Semin Arthritis Rheum. p.1269-1279. doi: 10.1016/j.semarthrit.2020.08.011.
Maguire, S., Wilson, F., Gallagher, P., Mohamed, M. M., Maher, S., & O'Shea, F. (2022). What to expect when women with axial spondyloarthritis are expecting: Prevalence of complications of pregnancies in women with axial spondyloarthritis. Semin Arthritis Rheum. doi: 10.1016/j.semarthrit.2022.151993.
Mann, L., Kleinpaul, F. J., Mota, B. C., & Santos, G. S. (2010). Alterações biomecânicas durante o período gestacional: uma revisão. Motriz Rio Claro, v.16(3)3 p.730-741. doi.org/10.5016/1980-6574.2010v16n3p730.
Oliveira, C, R, D. (2007). TSA Espondilite Anquilosante e Anestesia. Revista Brasileira de Anestesiologia v. 57(2), p. 214-222. doi.org/10.1590/S0034-70942007000200011.
Park, J. S., Chung, M. K., Lim, H., Lee, J., & Lee, C. H. (2022). Risk of Pregnancy Complications and Low Birth Weight Offsprings in Korean Women With Rheumatic Diseases: A Nationwide Population-Based Study. J Korean Med Sci, p. 18. doi: 10.3346/jkms.2022.37.e18.
Portaria conjunta n. 25, de 22 de outubro de 2018. (2018), Aprova o protocolo clinico e diretrizes terapêuticas da Espondilite Anquilosante. Recuperado de: https://www.gov.br/conitec/pt-br/midias/protocolos/20210428_pcdt-espondilite-ancilosante-1.pdf
Rabelo, C. F. (2016). Perfil de citocinas em pacientes com espondilite anquilosante. PUCRS Biblioteca Digital de Teses e Dissertações. Recupercdo de: https://tede2.pucrs.br/tede2/handle/tede/6993.
Relatório de Recomendaçao da Comissao Nacional de Incorporaçao de Tecnologias no SUS- CONITEC (2012) Medicamentos biológicos (Infliximabe, etanercept, Adalimumabe, rituximabe, abatacept e certolizumabe pegol) parao tratamento da artrite Reumatóide. Recuperado de: file:///D:/usuario/Downloads/biologicos-artritereumatoide-final.pdf.
Rocha, D., & Deusdará, B. (2005). Análise de Conteúdo e Análise do Discurso: aproximações e afastamentos na (re) construção de uma trajetória. ALEA. v. 7. n.2. p. 305 - 322.
Soares, A.C.E.S. (2017). Métrica vertebral: Alterações biomecânicas da coluna vertebral em indivíduos com Espondilite Anquilosante. Repositório universidade nova. Recuperado de: https://run.unl.pt/handle/10362/27912
Souza, M. T., Silva, M. D., & Carvalho, R. (2010). Revisão integrativa: oque é e como fazer. Einstein. v.8. n.1. p.102-106.
Smith, C.J.F., Bandoli, G., Kavanaugh, A., & Chambers, C. D. (2020). Birth Outcomes and Disease Activity During Pregnancy in a Prospective Cohort of Women With Psoriatic Arthritis and Ankylosing Spondylitis. Arthritis Care Res (Hoboken). p. 1029-1037. doi: 10.1002/acr.23924.
Ursin, K., Lydersen, S., Skomsvoll, J. F., & Wallenius, M. (2018). Disease activity during and after pregnancy in women with axial spondyloarthritis: a prospective multicentre study. Rheumatology (Oxford), p 1064-1071. doi: 10.1093/reumatologia/key047.
Van den Brandt, S., Zbinden, A., Baeten, D., Villiger, P. M., Østensen, M., & Förger, F. (2017). Risk factors for flare and treatment of disease flares during pregnancy in rheumatoid arthritis and axial spondyloarthritis patients. Arthritis Res Ther. p.64. doi: 10.1186/s13075-017-1269-1.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Pamella Moreira Almeida; Renata Caroline dos Anjos Nunes; Grace Arriello de Castro Piardi; Juliane Nadal Dias Swiech
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
